Itron (NASDAQ:ITRI) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen cut shares of Itron (NASDAQ:ITRI) from a buy rating to a hold rating in a research report report published on Wednesday morning.

Several other equities analysts have also recently issued reports on ITRI. Baird R W cut Itron from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 31st. Johnson Rice raised Itron from an “accumulate” rating to a “buy” rating and set a $130.00 target price on the stock in a research report on Monday, January 5th. Weiss Ratings reissued a “buy (b-)” rating on shares of Itron in a report on Monday, December 29th. Oppenheimer set a $145.00 price objective on shares of Itron and gave the company an “outperform” rating in a research report on Friday, October 31st. Finally, Zacks Research downgraded shares of Itron from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $138.10.

Itron Price Performance

NASDAQ:ITRI opened at $98.36 on Wednesday. Itron has a 52 week low of $90.11 and a 52 week high of $142.00. The company has a quick ratio of 1.91, a current ratio of 2.17 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average is $97.44 and its two-hundred day moving average is $116.56. The company has a market capitalization of $4.50 billion, a P/E ratio of 17.69, a P/E/G ratio of 0.55 and a beta of 1.49.

Itron (NASDAQ:ITRI) last released its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. The company had revenue of $581.63 million for the quarter, compared to analysts’ expectations of $578.49 million. Itron had a return on equity of 17.82% and a net margin of 10.69%.The firm’s revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. Equities analysts expect that Itron will post 5.33 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Donald L. Reeves III sold 536 shares of the stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $51,729.36. Following the completion of the sale, the senior vice president owned 19,068 shares of the company’s stock, valued at $1,840,252.68. This represents a 2.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Christopher E. Ware sold 343 shares of Itron stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $33,102.93. Following the completion of the sale, the senior vice president owned 18,774 shares in the company, valued at $1,811,878.74. The trade was a 1.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,971 shares of company stock valued at $286,731 over the last three months. 1.45% of the stock is owned by insiders.

Hedge Funds Weigh In On Itron

A number of institutional investors have recently added to or reduced their stakes in ITRI. Impax Asset Management Group plc grew its holdings in shares of Itron by 127.3% during the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after purchasing an additional 890,040 shares during the last quarter. Norges Bank acquired a new position in shares of Itron during the second quarter valued at about $71,727,000. Merewether Investment Management LP raised its stake in Itron by 1,552.7% during the 2nd quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock worth $39,593,000 after buying an additional 282,587 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Itron by 42.5% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock worth $75,306,000 after purchasing an additional 180,366 shares in the last quarter. Finally, Marshall Wace LLP grew its holdings in shares of Itron by 1,925.5% during the third quarter. Marshall Wace LLP now owns 186,873 shares of the scientific and technical instruments company’s stock valued at $23,277,000 after buying an additional 177,647 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.